Back
Company history
BioFocus was founded in 1997 by a group of former Wellcome scientists as a chemistry services company.
In 2001, BioFocus acquired biotechnology company Cambridge Drug Discovery, adding biology to its range of services. In October 2005, Galapagos acquired BioFocus. Following the acquisition of the Discovery Partners International operations, BioFocus DPI was formed - a provider of integrated gene-to-candidate discovery services.
Further acquisitions of Inpharmatica and Sareum's operations added ADME and structure-based drug discovery capabilities. This gave BioFocus DPI a full suite of target-to-candidate drug discovery products and services.
Print to HTML
Print as PDF
Send to a friend